12:00 AM
 | 
Mar 08, 1999
 |  BC Week In Review  |  Company News  |  Deals

Medarex, BankInvest Biomedical Development Venture Fund deal

MEDX and BankInvest created Genmab, a joint venture to develop human antibodies derived from MEDX's HuMAb-Mouse technology. BankInvest and other investors, including A/S Dansk Erhvervsinvestering,...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >